Exosomes isolated from the ascites of ovarian cancer patients can inhibit T-cell receptor (TCR)-dependent T-cell activation, affecting endpoints such as NF-κB and NFAT translocation, CD69 and CD107a upregulation, cytokine production, and cellular proliferation. This evidence concerns the gene NFKB1 and ovarian carcinoma.